La spesa annua stimata è pari a 220.500 euro
Risultati per: L’alcool danneggia il DNA e aumenta il rischio di cancro.
Questo è quello che abbiamo trovato per te
Giornata mondiale cancro, Schillaci: “Prevenire è fondamentale, forte impegno per adesione a screening e stili di vita corretti”
Comunicato del 04/02/2024 n°7
Web e ragazzi, il 12% è a rischio dipendenza da videogiochi
Sinpia: ‘Regole condivise, ma controproducente demonizzare’
Radiazioni da TC e rischio di neoplasie
Abstract 107: Exploring Non-Human DNA Content in Cerebral Thrombi Using Shotgun Metagenomic Sequencing
Stroke, Volume 55, Issue Suppl_1, Page A107-A107, February 1, 2024. Introduction:Prior studies that use 16S rRNA amplicon sequencing to profile bacterial components of cerebral thrombi do not provide species-level taxonomic information or functional gene content, which are critical for the development of subsequent clinical applications. To determine the amount and taxonomic nature of non-human DNA in cerebral thrombi, shotgun metagenomic sequencing was performed on specimens retrieved from ischemic stroke patients.Methods:Thrombi were retrieved during standard of care thrombectomy and preserved in DNA/RNA Shield (Zymo), alongside environmental controls. DNA was extracted per manufacturer instructions, using Zymo kits. Quality control was carried out using Bowtie2 and the bbtools suite. To clump reads, bbmap was applied. Sequencing adapter contamination was removed with bbduk. Data was aligned to the human reference genome (hg38) using Bowtie2. Tadpole (mode=correct, ecc=t, ecco=t) was used to correct sequencing errors. MetaSPAdes was used to assemble quality-controlled sequencing reads into contigs. CAT/BAT was then applied to annotate contigs and their Open Reading Frames (ORF) taxonomically using the Lowest Common Ancestor approach.Results:Of the 41 specimens, N = 31 met quality control. The preponderance of DNA sequencing reads mapped to the human genome. An average of 7,559,292 +/- 1,615,7061 (9.1%) reads per sample did not align (Fig 1A). Contigs resulting fromde novoassemblies of these potentially non-human reads contained sequences consistent with bacterial ORFs. The number of these ORFs varied per sample (Fig 1B) and correlated with the number of non-human reads.ProteobacteriaandFirmicutesdominated. (Fig 1C).Conclusion:While much work remains to optimize sequencing techniques and controls, the potential to recover near-complete bacterial genomes from thrombus presents an opportunity to further explore the human host-microbiota interactions in acute ischemic stroke.
Diagnostic Outcomes of Concurrent DNA/RNA Sequencing in Hereditary Cancer Testing
This diagnostic study assesses the outcomes of paired DNA and RNA testing on detection of disease-causing germline genetic variants and resolution of variants of uncertain significance.
Tumore del rene, l'immunoterapia dopo la nefrectomia riduce il rischio di morte
,Oncologo ‘cala il pericolo di metastasi, concreta possibilità di guarigione’
Tumore del rene, l'immunoterapia dopo la nefrectomia riduce il rischio di morte
,Oncologo ‘cala il pericolo di metastasi, concreta possibilità di guarigione’
La mortalità per tumori è in calo ma aumenta quella per il cancro al colon nei giovani
Colpa di obesità e alcol. Esperti: “Anticipare lo screening”
Mortalità per tumori in calo ma aumenta al colon nei giovani
Colpa di obesità e alcol. Esperti: “Anticipare lo screening”
Mortalità per tumori è in calo ma aumenta al colon nei giovani
Colpa di obesità e alcol. Esperti: “Anticipare lo screening”
Aiom, con l'Autonomia rischio di aumento delle disequità per le cure ai malati oncologici
Presidente Perrone, ‘Difendere l’universalismo delle cure’
Covid: indicatori tutti in calo, più a rischio gli over 80
Rt sui casi con ricovero ospedaliero a 0,60, sotto soglia
LIQUID-BIOPSY FOR ASSESSING SEVERITY OF INFLAMMATORY BOWEL DISEASE VIA PLASMA MICROBIAL CELL-FREE DNA
Plasma cell-free DNA (cfDNA) has emerged as a robust biomarker utilized in multiple applications that span cancer screening, diagnosis and monitoring, prenatal testing, and characterization of organ health post-transplantation. Cell-free DNA-based assays leverage the occurrence of processed extracellular DNA that produce unique signatures to discern a variety of biological states, disease manifestations, as well as forms of cell death. Similar to human cells, microbes produce cfDNA when they turnover, providing evident clinical utility in diagnosing and treating deep-seated infections in immunocompromised patients.
Autonomia: Aiom, rischio aumento disequità cure malati oncologici
Presidente Perrone: ‘Difendere l’universalismo delle cure’